Biogen's most recent trend suggests a bearish bias. One trading opportunity on Biogen is a Bear Call Spread using a strike $400.00 short call and a strike $410.00 long call offers a potential 40.85% return on risk over the next 32 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $400.00 by expiration. The full premium credit of $2.90 would be kept by the premium seller. The risk of $7.10 would be incurred if the stock rose above the $410.00 long call strike price.
The 5-day moving average is moving down which suggests that the short-term momentum for Biogen is bearish and the probability of a decline in share price is higher if the stock starts trending.
The 20-day moving average is moving down which suggests that the medium-term momentum for Biogen is bearish.
The RSI indicator is at 51.24 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Biogen
The Morning Download: Hardware Advances Bring Deep Learning, Real-Time Analytics Closer to Enterprise
Fri, 15 May 2015 12:37:34 GMT
Fidelity Adds to Biogen, Amazon and Sells Microsoft, Amex
Thu, 14 May 2015 22:11:32 GMT
Buy Microsoft, Biogen for Performance, Avoid Consumer Discretionary Stocks
Thu, 14 May 2015 20:42:00 GMT
Biogen Promotes Former Dell Exec as CIO to ‘Drive Innovation'
Thu, 14 May 2015 16:31:43 GMT
Biogen to Present at the 2015 UBS Global Healthcare Conference
Wed, 13 May 2015 20:01:00 GMT
Business Wire – Biogen Inc. announced today that it will present at the 2015 UBS Global Healthcare Conference. The webcast will be live on Tuesday, May 19, 2015 at 1:00p.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com.
Related Posts
Also on Market Tamer…
Follow Us on Facebook